Notable Stock to Watch: NuVasive (NASDAQ:NUVA)

NuVasive (NASDAQ:NUVA) changed 0.35% to recent value of $66.46. The stock transacted 615342 shares during most recent day however it has an average volume of 509.89K shares. It spotted trading -3.82% off 52-week high price. On the other end, the stock has been noted 52.75% away from the low price over the last 52-weeks.

On Oct. 30, 2019, NuVasive (NASDAQ:NUVA) the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, revealed financial results for the quarter ended September 30, 2019.

Third Quarter 2019 Highlights

  • Revenue increased 7.2% to $290.8 million, or 7.5% on a constant currency basis;
  • GAAP operating profit margin of 10.5%; Non-GAAP operating profit margin of 15.7%;
  • GAAP diluted earnings per share of $0.21; Non-GAAP diluted earnings per share of $0.59; and
  • Company raises full-year 2019 financial guidance.

In the third quarter 2019, NuVasive grew at multiples of market, with revenue increasing 7.2% driven by nearly double-digit organic growth within U.S. Hardware, said J. Christopher Barry, chief executive officer of NuVasive. In addition to strong topline results, our margin expansion demonstrates the ability to improve profitability with continued commitment to driving operational excellence. Based on the Company’s performance year to date, we are raising full-year 2019 financial guidance to reflect continued growth and confidence in the business.

NUVA has a gross margin of 72.30% and an operating margin of 8.40% while its profit margin remained 4.70% for the last 12 months. Its earnings per share (EPS) expected to touch remained -78.80% for this year while earning per share for the next 5-years is expected to reach at 10.45%.

The company has 52.05M of outstanding shares and 51.65M shares were floated in the market. According to the most recent quarter its current ratio was 3.6 that represents company’s ability to meet its current financial obligations. The price moved ahead of 2.58% from the mean of 20 days, 2.88% from mean of 50 days SMA and performed 11.71% from mean of 200days price. Company’s performance for the week was -0.61%, 9.02% for month and YTD performance remained 34.10%.

Leave a Reply

Your email address will not be published. Required fields are marked *